ATC code M04
| ATC code M: Musculo-skeletal system | 
|---|
  | 
| Other ATC codes | 
ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[5] 
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M04A Antigout preparations
M04AA Preparations inhibiting uric acid production
- M04AA01 Allopurinol
 - M04AA02 Tisopurine
 - M04AA03 Febuxostat
 - M04AA51 Allopurinol, combinations
 
M04AB Preparations increasing uric acid excretion
- M04AB01 Probenecid
 - M04AB02 Sulfinpyrazone
 - M04AB03 Benzbromarone
 - M04AB04 Isobromindione
 - M04AB05 Lesinurad
 
M04AC Preparations with no effect on uric acid metabolism
- M04AC01 Colchicine
 - M04AC02 Cinchophen
 - M04AC51 Colchicine and probenecid
 
M04AX Other antigout preparations
- M04AX01 Urate oxidase
 - M04AX02 Pegloticase
 
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
 - ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
 - ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
 - ↑ "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
 - ↑ "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.